Search

for
Search:

GlossaryTemsirolimus

medication that inhibits mTOR to treat advanced kidney cancer

Temsirolimus is a medication primarily used to treat advanced kidney cancer. It works by inhibiting a protein called mTOR, which plays a key role in cell growth and proliferation. By blocking this protein, Temsirolimus can help slow the growth of cancer cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 31 results

research Clinical Application of Nonantibiotic Macrolides for Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases

22 citations , January 2012 in “Mediators of inflammation”

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

research Dermatologic Adverse Events in Pediatric Patients Receiving Targeted Anticancer Therapies: A Pooled Analysis

26 citations , February 2015 in “Pediatric blood & cancer”

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

research Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies

44 citations , September 2015 in “Annals of Oncology”

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

research Adverse Hair Reactions to New Targeted Therapies for Cancer

1 citations , March 2019 in “Actas Dermo-Sifiliográficas”

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

research Prevention And Management Of Dermatological Toxicities Related To Anticancer Agents: ESMO Clinical Practice Guidelines

86 citations , November 2020 in “Annals of Oncology”

Early intervention and tailored management can reduce skin side effects from cancer treatments.

View more "temsirolimus" in research →

Community Join

0 / 0 results

— no results